Eisai Transfers Pariet Rights in China to CBC Group-Controlled Peak Pharma
Japan-based Eisai (TYO: 4523) announced a strategic decision to transfer the rights of its proton...
Insight, China's Pharmaceutical Industry
Fineline Insights, Pharma Clarity